Trojanowski Justin 4
4 · Tempest Therapeutics, Inc. · Filed Jul 2, 2024
Insider Transaction Report
Form 4
Trojanowski Justin
Corporate Controller
Transactions
- Purchase
Common Stock
2024-06-28$2.16/sh+7,500$16,200→ 22,168 total
Footnotes (1)
- [F1]Includes 14,668 shares acquired under the Issuer's stock purchase plan.